Pharming Group NV (PHARM) — Defensive Interval Ratio
Pharming Group NV (PHARM) has a Defensive Interval Ratio of 321 days as of September 2025. Defensive assets of €77.40 Million (cash €-, short-term investments €33.80 Million, receivables €43.61 Million) cover 321 days of daily cash needs of €240.86K/day. See Pharming Group NV (PHARM) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Pharming Group NV Defensive Interval Ratio (2005–2024)
This chart shows how Pharming Group NV's Defensive Interval Ratio has evolved across 20 annual periods from 2005 to 2024. As of September 2025, the ratio stands at 321 days, meaning defensive assets of €77.40 Million can fund 321 days of operations without new revenue. See PHARM net asset quality index to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Pharming Group NV (2005–2024)
The table below presents the year-by-year Defensive Interval Ratio for Pharming Group NV from 2005 to 2024, covering 20 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Pharming Group NV market cap and net worth.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 779 days | €157.48 Million | €202.20K/day | €- | €109.03 Million | ▼ -131 days |
| 2023 | 910 days | €175.89 Million | €193.37K/day | €- | €137.31 Million | ▲ +741 days |
| 2022 | 169 days | €27.62 Million | €163.56K/day | €- | €0.00 | ▼ -65 days |
| 2021 | 234 days | €29.95 Million | €128.00K/day | €- | €- | ▲ +83 days |
| 2020 | 151 days | €31.94 Million | €210.87K/day | €- | €- | ▲ +70 days |
| 2019 | 82 days | €25.62 Million | €312.68K/day | €- | €-661.91K | ▲ +11 days |
| 2018 | 71 days | €18.30 Million | €258.86K/day | €- | €- | ▲ +7 days |
| 2017 | 64 days | €12.22 Million | €192.37K/day | €- | €- | ▼ -17 days |
| 2016 | 81 days | €11.97 Million | €148.04K/day | €- | €- | ▼ 0 days |
| 2015 | 81 days | €3.27 Million | €40.36K/day | €- | €- | ▲ +46 days |
| 2014 | 35 days | €1.71 Million | €49.55K/day | €- | €- | ▲ +17 days |
| 2013 | 17 days | €849.24K | €48.90K/day | €- | €- | ▲ +1 days |
| 2012 | 17 days | €538.26K | €32.49K/day | €- | €- | ▼ -12 days |
| 2011 | 29 days | €830.24K | €28.89K/day | €- | €- | ▼ -64 days |
| 2010 | 93 days | €3.28 Million | €35.29K/day | €- | €- | ▲ +93 days |
| 2009 | 0 days | €0.00 | €142.37K/day | €- | €- | ▼ -109 days |
| 2008 | 109 days | €5.22 Million | €47.87K/day | €- | €5.22 Million | ▲ +109 days |
| 2007 | 0 days | €1.00 | €94.07K/day | €- | €- | ▲ +0 days |
| 2006 | 0 days | €0.00 | €33.24K/day | €- | €- | ▼ -435 days |
| 2005 | 435 days | €8.05 Million | €18.52K/day | €- | €6.92 Million | — |